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The paper will describe practical ways in which these skills 
might be of use to clinicians in a radiotherapy setting.  
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Due to advances in medical treatments such as surgery, 
radiotherapy, chemotherapy and hormonal therapy; it is 
expected that 68% of adults diagnosed with cancer today will 
be alive in 5 years time (Li et al 2014). 
This growth in the number of survivors who are living longer 
after cancer has generated increased attention to follow up 
care. Follow up care encompasses prevention, detection and 
treatment as well as the long term physical and psychological 
effects of cancer and its’ treatment (Forsythe et al 2014).  
The importance of assessing psychological distress at key 
points after a cancer diagnosis has been highlighted by 
several cancer networks. Distress can appear on a continuum 
ranging from common feelings of vulnerability and sadness to 
fears which may become disabling and lead to anxiety, 
depression or panic (Smith et al 2013). 
In the context of survivorship supports which aid an individual 
cope with their diagnosis of cancer and improve their quality 
of life become paramount. Support groups are an integral 
part of the support network and have been found to be very 
beneficial to both people directly affected by cancer and 
those close to them (Gottlieb & Wachala 2007). 
The average annual incidence of brain tumours in Ireland 
between 2008-2010 was 344. This was reported by the 
National Cancer Registry. This presentation will explore the 
Irish experience of a support group for people diagnosed with 
a brain tumour and the role of the RTT within it. It offers the 
RTT a different perspective on the people we treat everyday 
and how we can be of help to them. 
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In 1994, Eddie Naessens had a superficial parotidectomy to 
remove Adenoid Cystic Carcinoma. He was twenty-four at the 
time. A substantial recurrence was not diagnosed until 2001. 
Faced with a poor prognosis and conflicting advice he sought 
second opinions from cancer centres in the US and Europe. In 
2002, he underwent radical surgery followed by adjuvant RT 
at another Dublin hospital. 
His presentation connects his personal experience to work in 
social psychology. He discusses the psychological and social 
impact of diagnosis and treatment, his experience and 
insights dealing with an array of medical practitioner styles, 
and his fears and psychological approach to coping. He 
identifies what helped, what hindered and why it should 
matter to health professionals. Drawing on work in 
psychological research he frames his patient experience in a 
way that provides insights for both patients and 
practitioners. 
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Purpose/Objective: It is essential to engage patients in 
treatment decision making process. Slowly medical care is 
moving from emphasizing only 'survival' to 'quality' of 
existence of the individual. This study was done to assess the 
patient's perception about benefits of concurrent 
chemoradiation (CTRT) and various common side effects in 
treatment of Head Neck cancer. 
Materials and Methods: A prospective evaluation of decision 
making process for CTRT in head and neck cancers was done – 
pre CTRT, immediately after CTRT and 3 months after CTRT. 
The interviews consisted of a semi-structured questionnaire 
with free text options in some questions. There were 
questions on patient's views on Ryle's tube insertion, febrile 
neutropenia, nausea/vomiting and acceptance of morphine. 
They were also asked about their treatment preference on a 
hypothetical graded scale of survival benefit. Prior to the 
interview patients were updated about possible side effects 
of CTRT such they were are able to give a balanced view on 
their choices.  
Results: 30 patients with locally advanced head and neck 
cancer planned for CTRT were included in the study. Median 
age was 57 years (IQR 46 – 57.2 years) and 5 out 30 were 
women. Pre CTRT 80% (24/30) patients accepted to be 
treated by a Ryle's Tube as compared to 47% after 3 months 
of CTRT (x2 2.7, p<0.1). Pre CTRT 6/30 preferred not to be on 
a Ryle's at all based on 'past experience with Ryle's tube', 
'stigma of being seen with a Ryle's tube' and 'fear of pain'. 
Prior to CTRT, 83% (25/30) patients as compared to only 50% 
patient after 3 months of CTRT valued a 5% absolute survival 
benefit of CTRT. On 3 months post CTRT follow-up 53% 
patients felt that 6 weeks of CTRT was very painful period for 
them and one third of patients regretted taking CTRT. No 
significant fear observed among the patients for febrile 
neutropenic sepsis, nausea/vomiting. Acceptance for 
morphine was quite well throughout the therapy and most of 
them believe morphine is necessary for better pain control.  
Conclusions: Patient's preferences change over time and 
initially patients are more accepting of side effects and 
treatments with marginal benefits. Following CTRT almost 
50% patients do not value a 5% survival benefit and many 
regretted their decision to have CTRT. It's important that 
doctors are aware about patient's changing perceptions about 
the same treatment and discuss pros and cons of treatment 
in this context.  
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Purpose/Objective: The aim of this study is to evaluate 
knowledge and perception of radiation oncology (RO) by the 
Belgian general population. An online study in 2011 by 
Yougov in the UK, based on 2297 responses, observed a 
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generally negative perception of RO. The Belgian Radiation 
Oncology Awareness Organisation (BRAVO) is a collaborative 
platform of medical practitioners and industrial partners, 
created to evaluate and where required increase knowledge 
concerning radiation oncology by the general population, 
healthcare workers and policy makers. As a first step it was 
decided to assess the awareness of the general population. 
Materials and Methods: Between March and June 2014, data 
for this survey was collected during face-to-face streets 
interviews in all Belgian provinces. Questionnaires included 
fourteen questions articulated around four major themes: 
general awareness, efficacy, security and comfort, and 
innovation. Where required, open questions were used to 
avoid inducing answers. For most questions more then one 
answer was registered, and in that case the order of answers 
was noted. 
Results: Participants (n=746) were well balanced for gender 
and geographical distribution was homogeneous. Age 
distribution showed that a majority of participants was 
younger than 40 years (57%). We report here on a subset of 
questions. 
When looking at different therapeutic modalities for cancer, 
59 % of participants spontaneously cited RO as an option. 
However, when asked about the modality that offers the best 
cure chances, the RO score was well below surgery and 
chemotherapy with 13, 40 and 26% of positive answers 
respectively. Knowledge on treatment of cancer is mainly 
based on experiences in the personal environment (56%) and 
TV (37%), followed by written press (24%); the internet, 
school and hospitals being cited as other sources of 
information. 
On the safety issue, 33.8% of responders considered RO as an 
‘unsafe’ technique compared to 28.1% for whom it was 
‘safe’. RO was perceived as safe as chemotherapy, but less 
safe than surgery. Discussing potential side effects, 
participants seemed confused and cited problems induced by 
chemotherapy: 'hair loss' was more frequently mentioned 
(21%) than 'skin burns' (12%), with 36% having no idea about 
any radiotherapy toxicity. 
Lastly, asked about the treatment modality considered most 
innovative, radiotherapy came first (35%) before 
chemotherapy (31%) and surgery (16%). 
Conclusions: Knowledge of RO in Belgian general population 
is relatively poor and confusion with other treatment 
modalities exists. RT is not readily recognized as an effective 
treatment option and seems associated with insecurity. There 
is a clear need for future educational efforts targeted to the 
general population.  
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Purpose/Objective: Prospective evaluation of psychological 
variables including cut-off scores of psychological tests in 
aspect of outcome in  
head and neck cancer (HNC) patients treated by radiation 
alone, concurrent and sequential chemo-radiation. 
Materials and Methods: Eighty patients (women - 28%, men - 
72%, stage I/II - 17%, III - 15%, IV - 68%) were treated with by 
Accelerated Radiotherapy Alone (ARA - 60%) or Concurrent 
Chemo-Radiation (CCR - 40%) in some cases preceded by 
induction chemotherapy. The patients completed modified 
Hospital Anxiety and Depression Scale (HADS-M with 
additional aggression-irritability subscale), Distress 
Thermometer, Satisfaction with Life Scale, Visual–Analog 
Scales (VAS) of pain in HN area before (80 pts) and after (71 
pts) therapy. Clinical data, psychosocial and marital status of 
patients were included into the analysis as well.  
Results: Local control (LC) and overall survival (OS) rates at 3 
year follow-up were respectively 62% and 63%. At baseline, 
30% of patients were clinically depressed (15/42 or more 
points of general HADS score including depression and anxiety 
subscales). Overall HADS score was correlated with rates of 
3-year OS and LC, i.e. in patients with HADS <10p there were 
77% of LC and 73% of OS, but in HADS ≥10p there were 47% of 
LC and 54% of OS (p<0.021 and p<0.045, respectively). Fifty 
seven percent of patients reported baseline pain in HN area 
measured by VAS (42.5% - no pain, 27.5% - weak pain 1-3p, 
27.5% - moderate pain 4-6p, 2.5% - intense pain 7-10p). VAS 
score was correlated with rates of 3-year OS and LC, i.e. 
patients with moderate and intense pain of HN area (4-10p) 
had significantly lower LC and OS rates compare to patients 
with less pain (0-3p) – 29% and 32% versus 75% and 78%, 
respectively (p<0.00131, p<0.00033). Both HADS score and 
baseline VAS HN pain were not correlated with T and N stage, 
site of disease, age and sex. Baseline HADS score and HN pain 
intensity at baseline weakly correlated each other (R=0.24, 
p<0.05). Compared to the patients who had only CCR or ARA, 
induction chemotherapy group had 50% lower depression 
score after completing radiotherapy (p<0.05). Baseline C-
Reactive Protein level was related to increased depression 
and general higher HADS scores (R=0.31, p<0.05). Living 
alone without partner or family correlated with baseline HN 
pain (R=0.37, p<0.05) and stage of cancer (R=0.27, p<0.05). 
Conclusions: Baseline subclinical depressive symptomatology 
and elevated HN pain seem to play a significant role in the 
effectiveness of HNC radiation-related treatment, 
additionally to the other, well-known prognostic factors. 
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Ontologies can be used to increase data quality by describing 
the variables that are recorded in databases and the 
relationship between them. The definition of an ontology is 
“a formal description of the entities and the relationships 
between them for a given domain”. In radiation oncology, 
entities are classes like patients, diseases, CT-scans, 
radiotherapy treatments etc. and individuals like a specific 
MR scan or a specific treatment in a specific patient. 
Relationships can be simple such as specifying entities being 
sub classes, types, domains, ranges etc. of one another and 
data properties (e.g. dates) to more complex relationships 
such as a specific toxicity that occurred in a specific patient 
due to a specific radiotherapy treatment.  
